Efficacy and Safety of Elagolix in a Subgroup of Women With Uterine Fibroids and Adenomyosis: Results From a Phase 2 Trial
Fertility and Sterility - Netherlands
doi 10.1016/j.fertnstert.2018.07.186
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2018
Authors
Publisher
Elsevier BV